1. Simply complex: Essentialism trumps reductionism

   • Jeffrey R. Alberts

   Invited Commentary Pages: 379 - 381

2. Web alert

   News Pages: 382 - 383

3. Literature alert

   • Philip Buttery

   Abstract Pages: 384 - 385

4. Cholinesterase inhibitors in dementia

   • Karen Marder

   Clinical Trials Report Pages: 389 - 390

5. Cholinesterase inhibitors in dementia

   • Karen Marder

   Clinical Trials Report Pages: 390 - 391

6. Prevention of Alzheimer’s disease: Where we stand

   • Mary Sano

   OriginalPaper Pages: 392 - 399

7. Immunization treatment approaches in Alzheimer’s and prion diseases

   • Thomas Wisniewski
   • Einar M. Sigurdsson

   OriginalPaper Pages: 400 - 404

8. Anti-inflammatory agents in Alzheimer’s disease

   • Paul S. Aisen

   OriginalPaper Pages: 405 - 409

9. Chronic progressive external ophthalmoplegia

   • Andrew G. Lee
   • Paul W. Brazis

   OriginalPaper Pages: 413 - 417

10. Disorders of higher cortical visual function

    • James Goodwin

    OriginalPaper Pages: 418 - 422

11. Parasellar syndromes

    • Janine L. Johnston

    OriginalPaper Pages: 423 - 431

12. Ophthalmologic migraine

    • Robert F. Saul

    OriginalPaper Pages: 432 - 435

13. The genetics of Parkinson’s disease

    • Kah Leong Lim
    • Valina L. Dawson
    • Ted M. Dawson

    OriginalPaper Pages: 439 - 446

14. The spinocerebellar ataxias: Order emerges from chaos

    • Russell L. Margolis

    OriginalPaper Pages: 447 - 456

15. Transgenic mouse models of neurodegenerative disease: Opportunities for therapeutic development

    • Joanna L. Jankowsky
    • Alena Savonenko
    • David R. Borchelt

    OriginalPaper Pages: 457 - 464

16. Myotonic dystrophy: Clinical and molecular parallels between myotonic dystrophy type 1 and type 2

    • Laura P. W. Ranum
    • John W. Day

    OriginalPaper Pages: 465 - 470